Insider Selling: Integer Holdings Co. (ITGR) COO Sells 11,229 Shares of Stock
Integer Holdings Co. (NYSE:ITGR) COO Jeremy Friedman sold 11,229 shares of the company’s stock in a transaction dated Tuesday, December 12th. The stock was sold at an average price of $46.01, for a total transaction of $516,646.29. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
Integer Holdings Co. (NYSE ITGR) traded down $0.10 during trading on Wednesday, reaching $45.75. 122,800 shares of the company’s stock were exchanged, compared to its average volume of 187,465. The company has a current ratio of 2.58, a quick ratio of 1.37 and a debt-to-equity ratio of 1.95. Integer Holdings Co. has a 52 week low of $29.00 and a 52 week high of $55.20. The firm has a market cap of $1,450.00, a P/E ratio of 16.86, a PEG ratio of 1.17 and a beta of 1.07.
Integer (NYSE:ITGR) last released its earnings results on Thursday, October 26th. The medical equipment provider reported $0.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.78 by $0.04. Integer had a net margin of 1.42% and a return on equity of 11.22%. The company had revenue of $363.31 million for the quarter, compared to the consensus estimate of $354.83 million. During the same period in the prior year, the company posted $0.83 EPS. The company’s revenue was up 4.8% compared to the same quarter last year. research analysts expect that Integer Holdings Co. will post 2.62 earnings per share for the current fiscal year.
Several research analysts recently issued reports on the stock. BidaskClub upgraded shares of Integer from a “buy” rating to a “strong-buy” rating in a research report on Thursday, September 28th. Royal Bank of Canada reiterated a “neutral” rating on shares of Integer in a research report on Friday, October 27th. KeyCorp reiterated an “overweight” rating and set a $62.00 price target (up previously from $51.00) on shares of Integer in a research report on Monday, September 18th. Zacks Investment Research upgraded shares of Integer from a “sell” rating to a “hold” rating in a research report on Monday, August 21st. Finally, TheStreet upgraded shares of Integer from a “c+” rating to a “b-” rating in a research report on Wednesday, October 18th. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the stock. Integer currently has an average rating of “Hold” and an average target price of $51.00.
Integer Company Profile
Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.